Eloxx Pharmaceuticals, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ELOX, updated each market day.
ELOX AI Sentiment
AI predicts Eloxx Pharmaceuticals, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: June 23, 2025
Subscribers see precise scores, buy/sell targets, and full analytics.
About Eloxx Pharmaceuticals, Inc. Common Stock
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Sector
Exchange
Market Cap
$46,458,965
Cap Tier
Employees
7
Headquarters
ARLINGTON, MA
Listed Since
Dec. 11, 1998
Website
ELOX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ELOX Volatility
Eloxx Pharmaceuticals, Inc. Common Stock has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
